Skip to main content

Azacytidine inhibits the proliferation of human promyelocytic leukemia cells (HL60) by demethylation of MGMT, DAPK and p16 genes

Publication ,  Journal Article
Su, Y; Xu, H; Xu, Y; Yu, J; Xian, Y; Luo, Q
Published in: Hematology
January 2012

Duke Scholars

Published In

Hematology

DOI

EISSN

1607-8454

Publication Date

January 2012

Volume

17

Issue

1

Start / End Page

41 / 46

Publisher

Informa UK Limited

Related Subject Headings

  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Su, Y., Xu, H., Xu, Y., Yu, J., Xian, Y., & Luo, Q. (2012). Azacytidine inhibits the proliferation of human promyelocytic leukemia cells (HL60) by demethylation of MGMT, DAPK and p16 genes. Hematology, 17(1), 41–46. https://doi.org/10.1179/102453312x13221316477624
Su, Yongchun, Hongzhen Xu, Youhua Xu, Jie Yu, Ying Xian, and Qing Luo. “Azacytidine inhibits the proliferation of human promyelocytic leukemia cells (HL60) by demethylation of MGMT, DAPK and p16 genes.” Hematology 17, no. 1 (January 2012): 41–46. https://doi.org/10.1179/102453312x13221316477624.
Su, Yongchun, et al. “Azacytidine inhibits the proliferation of human promyelocytic leukemia cells (HL60) by demethylation of MGMT, DAPK and p16 genes.” Hematology, vol. 17, no. 1, Informa UK Limited, Jan. 2012, pp. 41–46. Crossref, doi:10.1179/102453312x13221316477624.
Su Y, Xu H, Xu Y, Yu J, Xian Y, Luo Q. Azacytidine inhibits the proliferation of human promyelocytic leukemia cells (HL60) by demethylation of MGMT, DAPK and p16 genes. Hematology. Informa UK Limited; 2012 Jan;17(1):41–46.

Published In

Hematology

DOI

EISSN

1607-8454

Publication Date

January 2012

Volume

17

Issue

1

Start / End Page

41 / 46

Publisher

Informa UK Limited

Related Subject Headings

  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
  • 1102 Cardiorespiratory Medicine and Haematology